MW XO Health Innovations Fund, LP — Form D/A
MW XO Health Innovations Fund, LP of CAMANA BAY, GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2022-03-08. $150.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-03-08
- Form: D/A
- Accession: 0000902664-22-002054
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.7
- Amount sold: $150.0M
- Investors: 1
- Date of first sale: 2021-04-07
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-391817
Issuer
- Name: MW XO Health Innovations Fund, LP
- CIK: 0001849328
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: C/O MW XO INNOVATIONS FUND GP LTD, CAMANA BAY, GRAND CAYMAN, E9, KY1-1103
- Phone: 44-0207-9257636
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alaina P Danley | Director | Camana Bay, Grand Cayman, E9 |
| Scott P Lennon | Director | Grand Cayman, E9 |
| Claire P Musgrave | Director | Camana Bay, Grand Cayman, E9 |
| - MW XO Health Innovations Fund GP Ltd | Executive Officer | Camana Bay, Grand Cayman, E9 |
| - P Marshall Wace Asia Limited | Promoter | Hong Kong, K3 |
| - P Marshall Wace LLP | Promoter | London, X0 |
| - P Marshall Wace North America L.P. | Promoter | New York, NY |
Other filings by this issuer (2)
More